Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Danning Tablet Under Lifestyle Intervention in Patients With Polypoid Lesions of Gallbladder: A Randomized, Open-labelled, Multicenter, Controlled Trial

NCT05668871 is registered in ClinicalTrials.gov with Eastern Hepatobiliary Surgery Hospital as lead sponsor.

NCT NCT05668871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05668871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Danning Tablet Under Lifestyle Intervention in Patients With Polypoid Lesions of Gallbladder: A Randomized, Open-labelled, Multicenter, Controlled Trial
Lead sponsor
Eastern Hepatobiliary Surgery Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2022
Completion date
February 25, 2026
Enrollment
326 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

multiple gallbladder polyps